title: Why is a new trial required to define the role of insulin reserve in newly diagnosed adult type 1 diabetes?
authors.affiliation: Clinical Research Unit, Medical Clinic 3 and Policlinic, Justus Liebig University, Giessen, Germany. thomas.linn@innere.med.uni-geissen.de
authors.forename: T
authors.initials: T
authors.lastname: Linn
authors.forename: M
authors.initials: M
authors.lastname: Mann
authors.forename: M
authors.initials: M
authors.lastname: Mann
authors.forename: R H
authors.initials: RH
authors.lastname: Boedeker
authors.forename: R G
authors.initials: RG
authors.lastname: Bretzel
mesh_terms: D000328:Adult; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000097:blood*; D012107:Research Design
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin